INMB vs TMO · rev $50.0K vs P/E 24, rev $23.00B
INmune Bio Inc (INMB) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
INMB currently screens at market cap $33.5M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the INMB and TMO stock pages for the full models.
Not investment advice.